Nuvalent Inc (NUVL)
69.16
-1.19
(-1.69%)
USD |
NASDAQ |
May 06, 15:34
Nuvalent Market Cap: 4.431B for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 4.507B |
| May 02, 2024 | 4.644B |
| May 01, 2024 | 4.526B |
| April 30, 2024 | 4.413B |
| April 29, 2024 | 4.353B |
| April 26, 2024 | 4.284B |
| April 25, 2024 | 4.233B |
| April 24, 2024 | 4.305B |
| April 23, 2024 | 4.331B |
| April 22, 2024 | 4.132B |
| April 19, 2024 | 4.021B |
| April 18, 2024 | 4.040B |
| April 17, 2024 | 4.116B |
| April 16, 2024 | 4.148B |
| April 15, 2024 | 4.182B |
| April 12, 2024 | 4.197B |
| April 11, 2024 | 4.357B |
| April 10, 2024 | 4.288B |
| April 09, 2024 | 4.485B |
| April 08, 2024 | 4.385B |
| April 05, 2024 | 4.498B |
| April 04, 2024 | 4.606B |
| April 03, 2024 | 4.741B |
| April 02, 2024 | 4.704B |
| April 01, 2024 | 4.939B |
| Date | Value |
|---|---|
| March 28, 2024 | 4.811B |
| March 27, 2024 | 4.910B |
| March 26, 2024 | 4.852B |
| March 25, 2024 | 4.897B |
| March 22, 2024 | 4.974B |
| March 21, 2024 | 5.096B |
| March 20, 2024 | 5.107B |
| March 19, 2024 | 5.002B |
| March 18, 2024 | 5.004B |
| March 15, 2024 | 5.177B |
| March 14, 2024 | 5.420B |
| March 13, 2024 | 5.664B |
| March 12, 2024 | 5.575B |
| March 11, 2024 | 5.359B |
| March 08, 2024 | 5.407B |
| March 07, 2024 | 5.347B |
| March 06, 2024 | 5.412B |
| March 05, 2024 | 5.216B |
| March 04, 2024 | 5.446B |
| March 01, 2024 | 5.585B |
| February 29, 2024 | 5.389B |
| February 28, 2024 | 5.469B |
| February 27, 2024 | 5.701B |
| February 26, 2024 | 5.549B |
| February 23, 2024 | 5.591B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
357.52M
Minimum
May 16 2022
5.701B
Maximum
Feb 27 2024
2.031B
Average
1.667B
Median
Mar 07 2023
Market Cap Benchmarks
| Geron Corp | 2.206B |
| Verastem Inc | 302.68M |
| Karyopharm Therapeutics Inc | 130.03M |
| Syndax Pharmaceuticals Inc | 1.921B |
| AnaptysBio Inc | 681.12M |
Market Cap Related Metrics
| Price to Book Value | 6.325 |
| Price | 69.16 |
| Earnings Yield | -3.12% |